Bengaluru, India

Nikhil Saji Zachariah

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Mitopower LLC. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nikhil Saji Zachariah. Retrieved from https://idiyas.com/inventor/nikhil-saji-zachariah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nikhil Saji Zachariah: Innovator in Pharmaceutical Science

Introduction

Nikhil Saji Zachariah is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative drug formulations. His work focuses on addressing medical disorders characterized by mitochondrial dysfunction.

Latest Patents

Nikhil holds a patent for "Prodrugs derived from nicotinic acid and ribose." This patent involves prodrugs of nicotinic acid that include ribosyl groups. The compounds and pharmaceutical compositions derived from this invention may be utilized to treat or prevent a variety of medical disorders, including metabolic, cardiovascular, cerebrovascular, liver, kidney, and muscle disorders.

Career Highlights

Nikhil is currently associated with Mitopower LLC, where he continues to advance his research and development efforts. His innovative approach to drug formulation has positioned him as a key player in the pharmaceutical industry.

Collaborations

Nikhil collaborates with notable colleagues, including Manoj Chandrasinhji Desai and Ajay Kumar K S. Their combined expertise enhances the research and development initiatives at Mitopower LLC.

Conclusion

Nikhil Saji Zachariah is an influential inventor whose work in pharmaceutical science is paving the way for new treatments for various medical disorders. His dedication to innovation and collaboration is making a significant impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…